Drug Target Review – Issue 4 2019

Posted: 10 December 2019 | | No comments yet

This issue includes a discussion on the future of high-throughput screening through collaboration, an analysis of mass spectrometry as a structural biology tool and an exploration of the challenges of hit-to-lead when researching tropical diseases. Also in the issue are articles on immuno-oncology and assays. 

Included in this issue:

    CRISPR: kick‑starting the revolution in drug discovery
    Dr Pushpanathan Muthuirulan, Harvard University
    Antibody characterisation – an essential researchers’ resource
    Dr Tara Hiltke, National Cancer Institute
    A novel approach to unravelling the mysteries of Alzheimer’s
    Professor Tuomas Knowles, University of Cambridge
    Dr Sean Devenish, Fluidic Analytics
    Getting precise: how humanised models aid in biologics drug discovery
    Paul Volden, Taconic Biosciences
    Transitioning novel peptide hits into lead compounds
    Steven A Trim, Venomtech
    Dr Carol M Trim, Canterbury Christ Church University

The rest of this content is restricted - login or subscribe free to access

DTR Issue 3 2021 MiniMagThank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • quarterly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here